Porphirya cutanea tarda (PCT) has been reported inHIV-1-infected individuals [1,2]. It has been related toHIV [1,2], other viral infections (hepatitis C virus; HCV)[3] alcohol abuse and antiretroviral therapy (ART) [4,5].We describe for the first time a case of PCT that developedduring ART switch, after the introduction of tipranavir/ritonavir to a backbone with tenofovir and lamivudine.
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report
CELESIA BM;NUNNARI G;
2007-01-01
Abstract
Porphirya cutanea tarda (PCT) has been reported inHIV-1-infected individuals [1,2]. It has been related toHIV [1,2], other viral infections (hepatitis C virus; HCV)[3] alcohol abuse and antiretroviral therapy (ART) [4,5].We describe for the first time a case of PCT that developedduring ART switch, after the introduction of tipranavir/ritonavir to a backbone with tenofovir and lamivudine.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2007_AIDS_tipranavir.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
468.67 kB
Formato
Adobe PDF
|
468.67 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
